Spots Global Cancer Trial Database for raltitrexed
Every month we try and update this database with for raltitrexed cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fruquintinib Plus S-1 and Raltitrexed (RSF) for mCRC | NCT06427005 | Fruquintinib S-1 Raltitrexed | Fruquintinib S-1 raltitrexed | 18 Years - | West China Hospital | |
| Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | NCT00002828 | Colorectal Canc... | fluorouracil raltitrexed | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus | NCT03585530 | Esophagus Squam... | raltitrexed | 70 Years - 85 Years | Huai'an First People's Hospital | |
| Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients | NCT05426811 | Regorafenib Raltitrexed Colorectal Neop... Third-line Trea... | Regorafenib Raltitrexed | 18 Years - | China Medical University, China | |
| Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients | NCT03053167 | ColoRectal Canc... | Irinotecan Raltitrexed | 18 Years - 75 Years | China Medical University, China | |
| A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer | NCT01732380 | Inoperable Esop... | Raltitrexed Oxaliplatin Radiotherapy | 18 Years - 80 Years | The First People's Hospital of Lianyungang | |
| Raltitrexed in Treating Children With Refractory Acute Leukemia | NCT00003528 | Recurrent Child... Recurrent Child... | raltitrexed | - 21 Years | National Cancer Institute (NCI) | |
| A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer | NCT01836120 | Gastric Cancer | Raltitrexed plu... Docetaxel | 18 Years - 75 Years | Hebei Tumor Hospital | |
| The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer | NCT05628038 | Recurrent Recta... | PD-1 antibody Capecitabine 5FU folinic acid Oxaliplatin Irinotecan Raltitrexed Radiation | 18 Years - 75 Years | Fudan University | |
| Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly | NCT02992886 | Rectal Neoplasm... | Preoperative ra... Raltitrexed Pelvic surgery | 71 Years - | ChineseAMS | |
| Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure | NCT01348412 | Colorectal Canc... Liver Metastase... | oxaliplatin raltitrexed other intraveno... | 18 Years - 75 Years | Centre Georges Francois Leclerc | |
| Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases | NCT01959061 | Colorectal Canc... | Raltitrexed Oxaliplatin lipiodol | 18 Years - 75 Years | Nanjing Chia-tai Tianqing Pharmaceutical | |
| Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer | NCT04582981 | Advanced Colore... | Fruquintinib an... Fruquintinib | 18 Years - | Fudan University | |
| Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases | NCT01959061 | Colorectal Canc... | Raltitrexed Oxaliplatin lipiodol | 18 Years - 75 Years | Nanjing Chia-tai Tianqing Pharmaceutical | |
| Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC. | NCT03196843 | Head and Neck S... | Raltitrexed Intensity Modul... | 65 Years - | The First Affiliated Hospital of Dalian Medical University | |
| A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer | NCT04499586 | Recurrent Color... | Radiotherapy Co... | 18 Years - 75 Years | Fudan University | |
| Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00002893 | Colorectal Canc... | fluorouracil leucovorin calc... raltitrexed | - | National Cancer Institute (NCI) | |
| Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer | NCT04582981 | Advanced Colore... | Fruquintinib an... Fruquintinib | 18 Years - | Fudan University | |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | NCT00004254 | Malignant Mesot... | raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC | NCT04597970 | Transarterial C... Hepatocellular ... | cTACE-HAIC | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer | NCT04241731 | Colorectal Canc... | Raltitrexed Cetuximab | 18 Years - 75 Years | Jiangsu Cancer Institute & Hospital | |
| Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer | NCT06118762 | Metastatic Colo... | Fruquintinib | 18 Years - | The First Affiliated Hospital of Nanchang University | |
| Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors | NCT00003109 | Unspecified Adu... | irinotecan hydr... raltitrexed | 18 Years - | Fox Chase Cancer Center | |
| Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer | NCT02723253 | Rectal Neoplasm... | Radiotherapy Tom-OX | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC | NCT04597970 | Transarterial C... Hepatocellular ... | cTACE-HAIC | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly | NCT02992886 | Rectal Neoplasm... | Preoperative ra... Raltitrexed Pelvic surgery | 71 Years - | ChineseAMS | |
| Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura | NCT00004920 | Malignant Mesot... | cisplatin raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer | NCT03126071 | Advanced Colore... | Raltitrexed Irinotecan Oxaliplatin Bevacizumab | 18 Years - 70 Years | Jiangsu Cancer Institute & Hospital | |
| A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer | NCT01836120 | Gastric Cancer | Raltitrexed plu... Docetaxel | 18 Years - 75 Years | Hebei Tumor Hospital | |
| Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer | NCT02485548 | Head and Neck S... | Raltitrexed 5-fluorouracil Cisplatin IMRT | 18 Years - 70 Years | Jiangsu Cancer Institute & Hospital | |
| Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors | NCT00002902 | Unspecified Adu... | irinotecan hydr... raltitrexed | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer | NCT05628038 | Recurrent Recta... | PD-1 antibody Capecitabine 5FU folinic acid Oxaliplatin Irinotecan Raltitrexed Radiation | 18 Years - 75 Years | Fudan University | |
| Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab | NCT06408584 | Esophageal Squa... | 18 Years - | Anhui Provincial Hospital | ||
| Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer | NCT01481545 | Rectal Cancer | Radiation thera... Oxaliplatin Raltitrexed levofolinic aci... 5-fluorouracil Bevacizumab | 18 Years - | National Cancer Institute, Naples | |
| Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer | NCT02821559 | Metastatic Colo... | TOMOX Bevacizumab | 18 Years - 80 Years | Centre Hospitalier Universitaire de Besancon | |
| Fruquintinib Plus S-1 and Raltitrexed (RSF) for mCRC | NCT06427005 | Fruquintinib S-1 Raltitrexed | Fruquintinib S-1 raltitrexed | 18 Years - | West China Hospital | |
| Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia | NCT03823079 | Recurrent Color... Thrombopenia | rhTPO irinotecan Raltitrexed radiotherapy rhIL-11 | 18 Years - 75 Years | Fudan University | |
| Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer | NCT04582981 | Advanced Colore... | Fruquintinib an... Fruquintinib | 18 Years - | Fudan University | |
| Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00002893 | Colorectal Canc... | fluorouracil leucovorin calc... raltitrexed | - | National Cancer Institute (NCI) | |
| Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer | NCT03126071 | Advanced Colore... | Raltitrexed Irinotecan Oxaliplatin Bevacizumab | 18 Years - 70 Years | Jiangsu Cancer Institute & Hospital | |
| Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer | NCT02821559 | Metastatic Colo... | TOMOX Bevacizumab | 18 Years - 80 Years | Centre Hospitalier Universitaire de Besancon | |
| Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy | NCT05435313 | Colorectal Canc... | HAIC Fruquintinib Tislelizumab Raltitrexed Oxaliplatin Irinotecan | 18 Years - 75 Years | Fudan University | |
| Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | NCT02376452 | Colorectal Carc... | Raltitrexed Irinotecan 5-fluorouracil Leucovorin | 18 Years - 70 Years | Fudan University | |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | NCT00004254 | Malignant Mesot... | raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Raltitrexed in HIPEC | NCT04761185 | Colorectal Canc... Raltitrexed HIPEC | Raltitrexed | 18 Years - 75 Years | Fudan University | |
| A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer | NCT04499586 | Recurrent Color... | Radiotherapy Co... | 18 Years - 75 Years | Fudan University | |
| The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer | NCT05628038 | Recurrent Recta... | PD-1 antibody Capecitabine 5FU folinic acid Oxaliplatin Irinotecan Raltitrexed Radiation | 18 Years - 75 Years | Fudan University | |
| A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer | NCT01732380 | Inoperable Esop... | Raltitrexed Oxaliplatin Radiotherapy | 18 Years - 80 Years | The First People's Hospital of Lianyungang | |
| Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC. | NCT03196843 | Head and Neck S... | Raltitrexed Intensity Modul... | 65 Years - | The First Affiliated Hospital of Dalian Medical University | |
| Raltitrexed in Treating Children With Refractory Acute Leukemia | NCT00003528 | Recurrent Child... Recurrent Child... | raltitrexed | - 21 Years | National Cancer Institute (NCI) | |
| Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia | NCT03823079 | Recurrent Color... Thrombopenia | rhTPO irinotecan Raltitrexed radiotherapy rhIL-11 | 18 Years - 75 Years | Fudan University | |
| RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study) | NCT03813641 | Colorectal Canc... | Raltitrexed Capecitabine | 18 Years - 75 Years | Shenzhen People's Hospital | |
| Raltitrexed in HIPEC | NCT04761185 | Colorectal Canc... Raltitrexed HIPEC | Raltitrexed | 18 Years - 75 Years | Fudan University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
